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Edited by Jesus AvilaAbstract a-Synuclein phosphorylated at Ser129 is the main
component of Lewy bodies of Parkinson’s and closely related
diseases. We studied, by quantitative immunoblotting, changes in
the phosphorylation level of a-synuclein in the mouse brains
subjected to cold water stress. Relative basal level of a-synuclein
phosphorylation at Ser129 was 40% higher in the striatum
compared with the hippocampus. The phosphorylation level
decreased to 57% in the striatum 20 min after 5 min of cold
water stress, and also in the hippocampus and cortex to lesser
degrees. Recovery to basal levels took place over several hours.
The stress-induced temporary dephosphorylation was of smaller
magnitude in the striatum of aged (18 months) mice. These
results show that a-synuclein phosphorylation level at Ser129 in
vivo responds to physiological stimuli. Relative prominence and
age sensitivity of this phenomenon in the striatum may be
relevant to the pathogenesis of Parkinson’s disease.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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a-Synuclein is a major protein component of Lewy bodies
(LB), the histopathological hallmark of Parkinson’s disease
(PD) and dementia with LBs (DLB) [1,2]. Two mutations in
the a-synuclein gene have been found to cause familial forms
of PD characterized by extensive loss of nigral dopaminergic
neurons and loss of dopamine in the striatum, St [3,4]. A recent
study linked triplication of the a-synuclein locus to a familial
PD [5]. Studies of transgenic rodents and Drosophila models
strongly implicate a-synuclein in the degeneration of dopa-
minergic neurons, but its molecular mechanisms remain to be
clariﬁed [6].* Corresponding author. Fax: +81-42-724-6316.
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Abbreviations: CK, casein kinase; CWS, cold water stress; DLB,
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LB, Lewy body; PD, Parkinson’s disease; SDS, sodium dodecylsulfate;
St, striatum; VP, ventroposterior quadrant of the cerebral hemisphere
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doi:10.1016/j.febslet.2004.07.046a-Synuclein is a neuronal protein particularly abundant in
forebrain structures in rodents and humans [7,8], localized
mainly in pre-synaptic terminals and in the neighborhood of
synaptic vesicles [9–11], and suggested to be involved in traf-
ﬁcking of synaptic vesicles [12,13]. A drastic increase in the
transcription of synelphin, the zebra ﬁnch a-synuclein homo-
logue, during the development of the song control system has
been observed [14]. a-Synuclein knockout mice with normal
brain architecture exhibit a defect in synaptic physiology
[15,16]. These ﬁndings indicate that a-synuclein has a physio-
logical role in synaptic function.
Recent analyses have shown that most of the a-synuclein
deposited in brains with DLB as well as other related disorders
is phosphorylated at Ser129 [17], and a fraction of the phos-
phorylated a-synuclein is further monoubiquitinated at two
lysines [18]. Interestingly, tau protein in neuroﬁbrillary tan-
gles, a hallmark of Alzheimer’s disease, is also hyperphosph-
orylated and ubiquitinated [19,20]. We previously reported
reversible tau hyperphosphorylation in normal mice in re-
sponse to physical stress such as starvation and cold water
[21–23]. Here, we took advantage of a speciﬁc phosphoryla-
tion dependent a-synuclein antibody to determine the eﬀect of
a brief cold water stress (CWS) on the phosphorylation level
of a-synuclein in the St and other regions of the normal mouse
brain.2. Materials and methods
2.1. Animals
Male C57BL/6Njcl mice (10–13 weeks or 18 months, Clea Japan,
Tokyo) weighing 25.0 3.0 g were allowed free access to a standard
chow and water, maintained at 23 C and under light period of 08:00–
20:00, and used in compliance with the protocols approved by the
Animal Care and Use Committee of Mitsubishi Kagaku Institute of
Life Sciences.
2.2. Cold water stress
CWS was given between 13:00 and 18:00. Mice were put in ice-
chilled water of 7 cm depth in a 16 cm diameter ceramic container for 5
min, after which they were gently wiped dry and returned to the cages
[23]. Mice were killed by cervical dislocation at designated times after
CWS.
2.3. Western blot analysis
The brains were removed immediately after sacriﬁce and placed in
ice-chilled saline. Brain regions were quickly removed by manual
dissection under a dissecting microscope: right St, both hippocampi,
right ventroposterior quadrant of the cerebral hemisphere (VP) and
either half of cerebellum. The tissues were immediately homogenized
using a Physcotron microhomogenizer (NS-310E, Microtech Nichion)ation of European Biochemical Societies.
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glycerol, 5% (v/v) 2-mercaptoethanol, 2.3% (w/v) sodium dodecyl-
sulfate (SDS), 5 mM NaF, 100 lM orthovanadate, 1 lM okadaic
acid, 1 mM PMSF, 1 mM EDTA, and 1 mM EGTA) [22]. The
tissues were handled quickly, so that homogenation was within 2.5–4
min of cervical dislocation, as the postmortem lability of phosphate
bound to a-synuclein is known [17]. Protein concentration was de-
termined after dilution with saline by Bio-Rad Protein Assay with
BSA in O+ buﬀer as standard.
Samples (15 lg protein/lane) were run on 15% acrylamide SDS–
PAGE followed by electrophoretic transfer to PVDF membrane
(Immobilon-P, Millipore) for 45 min at 8 V in a Trans-Blot SD Cell
(Bio-Rad). Membrane was reacted with anti-phospho-a-synuclein an-
tibody (PSer129) [17,24] overnight and then with blotting grade aﬃnity
puriﬁed goat anti-mouse IgG peroxidase conjugated (170-6516, Bio-
Rad). For anti-a-synuclein (S-3062, Sigma), anti-synaptophysin
(mouse monoclonal, 171B5) [25], and anti-phosphorylated tau (mouse
monoclonal, AT8), nitrocellulose membrane (Protran BA 85, Schlei-
cher & Schuell) was used, and the secondary antibodies were goat anti-
rabbit or mouse IgG-horseradish peroxidase (HRP) (sc-2030, sc-2031,
Santa Cruz). Chemiluminescence signals from the blots were obtained
and quantiﬁed using SuperSignal West Pico (Pierce) and LAS-
1000plus image analyzer with Image Gauge 3.0 software (Fujiﬁlm).
Band signal intensity was approximately linear to the input protein
under the conditions used. Statistical signiﬁcance was evaluated by
one-way analysis of variance (ANOVA) and the Tukey/Kramer test of
pairwise multiple comparisons. In all ﬁgures, error bars represent
standard deviation, and * and ** indicate signiﬁcant diﬀerence with
P < 0:05 and P < 0:01, respectively.3. Results
3.1. Immunoblot identiﬁcation of phosphorylated a-synuclein in
the mouse brain
Anti-PSer129 is a monoclonal antibody speciﬁc to a-synuc-
lein phosphorylated on Ser129 as previously shown with ex-
tracts of human brain [24]. C-terminal 18 amino acids
encompassing Ser129 are totally conserved between human
and mouse [7]. Previous analysis estimated that 4% of a-
synuclein is phosphorylated in the normal rat brain [17]. TheFig. 1. Immunoblot identiﬁcation of mouse a-synuclein band in a ce-
rebral extract. Aliquots of mouse cerebral extract (10 lg protein) were
immunoblotted. Blot carrying lane 1 was stained with Ponseau S for
protein. The strip for lanes 2–4 was split in the middle and probed with
anti-a-synuclein or anti-phospho-a-synuclein PSer129 antibodies as
indicated. Molecular weights in kDa are given on the left.antibody PSer129 was used to identify the band of phos-
phorylated a-synuclein in immunoblots of mouse brain whole
extracts (Fig. 1). An immunoreactive band of a 17 kDa was
detected (lane4), which registered with the a-synuclein band as
detected with the anti-a-synuclein antibody (lane 2) when the
two halves of the split lane were juxtaposed (lane 3). Thus,
phosphorylation of a-synuclein at Ser129 does not cause a
detectable mobility shift of the a-synuclein band.3.2. a-Synuclein is more highly phosphorylated in the St than in
the hippocampus or ventroposterior cerebral hemisphere
Relative content of a-synuclein was determined for St, hip-
pocampus (Hc), VP, and cerebellum (Fig. 2A). VP comprises
the amygdala, entorhinal cortex, and some neocortex, and has
been shown to exhibit robust tau hyperphosphorylation after
CWS [23]. The content of a-synuclein was highest in the Hc
and VP followed by the St, while in the cerebellum the abun-
dance was 11% of that of the Hc. Content of a-synuclein
phosphorylated at Ser129 was highest in the St and VP
(Fig. 2B). Synaptophysin, another presynaptic protein, was
also more abundant in the St, Hc and VP, but the cerebellar
synaptophysin content was about 52% of that of the Hc
(Fig. 2C).
The ratio of anti-PSer129 to anti-a-synuclein signals for the
four brain regions of each mouse was calculated as a measure
of the fraction of a-synuclein phosphorylated at Ser129
(Fig. 2D). The ratio, averaged over six animals, was highest for
the St (1.3, arbitrary unit) compared with the Hc (0.9) and VP
(1.0). Meaningful values were not obtained for the cerebellum
due to weak signals.3.3. Cold water stress induces a-synuclein dephosphorylation
most prominently in the St
To gain clues to the physiological signiﬁcance of a-synuclein
phosphorylation, we tested whether stressful stimuli to mice
will cause changes in the phosphorylation level of this protein
in the brain. Batches of six young adult mice were subjected to
forced swimming in ice-chilled water for 5 min, and after
various periods of recovery, three brain regions were quickly
taken. The tissue extracts were individually analyzed by
quantitative immunoblotting with anti-a-synuclein and phos-
phorylation-dependent a-synuclein antibody anti-PSer129.
No changes in the protein level of a-synuclein were observed
in each of the three regions (Fig. 3A–D, white bars). By con-
trast, phosphorylation level at Ser129 decreased to approxi-
mately 57% of control in the St at 20 min after CWS (Fig. 3A
and B, black bars). Thereafter, the phosphorylation level
slowly returned toward the control level, but did not show full
recovery at 24 h after CWS. In these striatal extracts, robust
phosphorylation of tau could be demonstrated, as illustrated
by a phosphorylation-dependent anti-tau antibody, AT8
(Fig. 3A, bottom).
In the Hc the decrease in the phosphorylation level of a-
synuclein was signiﬁcant at 20 min after CWS (Fig. 3C). A
clear decrease to 60% at 20 min was observed in the VP and the
gradual recovery was complete after 24 h (Fig. 3D). We pre-
viously reported on sharp and temporary hyperphosphoryla-
tion of tau in the Hc and VP after CWS [23]. Thus, brief CWS
induced temporary decreases in the phosphorylation level of a-
synuclein most prominently in the St. Similar changes were
observed in the VP and less robustly in the Hc.
Fig. 3. Dephosphorylation of a-synuclein after CWS. Young adult (3 months) mice were subjected to 5 min of CWS and allowed to recover for
various periods. Control mice received no CWS (cont.). Panel A shows representative immunoblots with anti-a-synuclein, anti-phospho-a-synuclein,
and anti-phosphorylated tau antibodies for the St with three mice for each condition. Band intensities were quantiﬁed and normalized with respect to
internal reference samples (Panels B–D) for a-synuclein protein (white bars) and the phosphorylated protein (p-syn, black bars). Graphs present
quantitative results with six mice for each time point for the brain regions indicated. ** in Panels B and D indicates signiﬁcant diﬀerence from
respective control and 0 min values at P < 0:01, while * indicates signiﬁcant diﬀerence from the control value in the hippocampus (C), or from control
and 0 min values in the St (B) at P < 0:05.
Fig. 2. Relative levels of a-synuclein, phospho-a-synuclein, and synaptophysin in selected regions of mouse brain. Extracts (15 lg protein) of St, Hc,
ventroposterior quadrant of the cerebral hemisphere (VP) and cerebellum (Cbl) from six untreated mice were analyzed. The immunoblots in A–C
illustrate the results of three mice with the three antibodies as indicated. Band intensities were quantiﬁed and normalized with respect to internal
reference samples. Graphs summarize band signal quantiﬁcation (arbitrary unit) based on analyses of six mice. Panel D shows relative phosphor-
ylation levels of a-synuclein (phospho-a-synuclein signal divided by a-synuclein signal) in the three brain regions. Data are presented as
meansS.D.; ** indicates signiﬁcant diﬀerence from St at P < 0:01.
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Fig. 4. Comparison of a-synuclein and phospho-a-synuclein levels in selected brain regions between young adult (3 months) and aged(18 months)
mice. Panel A shows immunoblots of the striatal extracts from 9 young and 7 aged mice probed with anti-a-synuclein (upper blot) and anti-phospho-
a-synuclein (PSer129) antibodies (lower blot). Panels B–D present quantitative summary of band intensities for the three brain regions. * and **
indicate signiﬁcant diﬀerence from young adults at P < 0:05 and P < 0:01, respectively.
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Fig. 5. a-Synuclein and phospho-a-synuclein levels in the three brain
regions of aged (18 months) mice after 5 min of CWS and various
periods of recovery. Control mice received no CWS (cont.). Numbers
in parenthesis at the bottom of Panel A show the number of animals
analyzed for each condition. * and ** indicate signiﬁcant diﬀerence
from controls at P < 0:05 and P < 0:01, respectively.
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aged St
Decrease in dopamine in the St is an early and the most
conspicuous neurochemical change known in aging brains of
mice as well as humans [26,27]. It was therefore of interest to
study changes in a-synuclein and its phosphorylation level in
the St and other selected regions in aging mice.
Quantitative immunoblots probed with anti-a-synuclein
antibody showed no diﬀerence in the abundance of this protein
in the St between young adult (3 months) and aged (18
months) mice (Fig. 4A, upper blot; 4B). Blotting with anti-
phospho-a-synuclein antibody revealed a signiﬁcant decrease
in its phosphorylation level in the aged mice (Fig. 4A, lower;
4B). In the Hc, a tendency toward decreased levels of both a-
synuclein protein and phosphorylation was observed (Fig. 4C),
but statistical signiﬁcance for the latter was not attained. In the
VP, a signiﬁcant decrease in a-synuclein was accompanied by a
comparable decrease in the level of phosphorylated a-synuc-
lein (Fig. 4D). Thus, the St characteristically showed a de-
crease in the phosphorylated fraction of a-synuclein with
aging.
3.5. a-Synuclein dephosphorylation response to CWS in aged
mice
Eﬀect of aging on the stress response of a-synuclein phos-
phorylation level was studied using 26 mice of 18 months of
age. No signiﬁcant changes in the a-synuclein protein levels
were observed in each of the three brain regions studied during
up to 24 h after CWS (Fig. 5A–C, white bars). Signiﬁcant
decreases in the phosphorylation levels were observed in the St
at 20 min and at 4 h after CWS (Fig. 5A, black bars). The
decrease at 20 min was 21% from the control, a smaller de-
crease compared to the young mice (Fig. 3B). In the Hc and
VP (Fig. 5B and C), decreases in the phosphorylation level
were observed with signiﬁcance at 20 min after CWS, and the
return to the control levels was complete by 4 h. These results
indicate that the stress response to CWS in terms of temporary
decreases in the phosphorylation level of a-synuclein becomes
attenuated in the aged St.
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We found that the phosphorylated fraction of a-synuclein in
the mouse brain varies according to the regions: in the St it was
44% higher than in the Hc and 30% higher than in the cortex
neighboring the Hc (VP). This phosphorylation level showed a
43% decrease 20 min after 5 min of forced swimming in cold
water. Decreases were also observed in the Hc and VP. The
phosphorylation level gradually returned to the basal levels
over hours. This temporary dephosphorylation of a-synuclein
was also observed in the three brain regions of aged mice (18
months), although the extent of change was less marked.
4.1. a-Synuclein phosphorylation
Studies with transfected cells showed initially that a-synuc-
lein is phosphorylated constitutively [28] and experiments with
a rat brain extract demonstrated in vitro incorporation of ra-
dioactive phosphate into a-synuclein [29]. Casein kinase 2
(CK2) and 1 (CK1) [28], and G protein-coupled receptor ki-
nases [29] were implicated in a-synuclein phosphorylation in
the cultured cells. Fujiwara et al. [17] showed pathological
phosphorylation of a-synuclein at Ser129 in human brains and
a-synuclein phosphorylation was demonstrated in Drosophila
transgenically expressing human a-synuclein [30]. We here
studied physiological levels of Ser129 phosphorylation in four
regions of the normal mouse brain. Our ﬁnding that a-syn-
uclein is relatively highly phosphorylated in the normal St
suggests that certain neuronal subsystems in which Ser129
phosphorylation plays an important role may be more pre-
valent in the St than in other regions of the brain.
4.2. Physiological a-synuclein dephosphorylation
We report for the ﬁrst time that a physiological stimulus
induces changes in the phosphorylation level of a-synuclein in
the brain. It has been shown that stress such as starvation and
CWS causes reversible hyperphosphorylation of tau protein in
the Hc and cortex of the mouse brain [20–23]. Since there
seemed to be a certain parallel between tau and a-synuclein,
two ‘‘natively unfolded’’ proteins that form intraneuronal de-
posits in Alzheimer’s disease and PD, respectively, it was of
interest to examine how phosphorylation of a-synuclein in vivo
would respond to stressful stimuli. Tail shock stress has been
shown to elicit dopamine release in the rat St [31], and stress in
general has been discussed as a key factor in the loss of do-
pamine neurons [32].
Our discovery of clear temporary dephosphorylation of a-
synuclein after CWS indicates that phosphorylation of a-syn-
uclein is likely to have a physiological signiﬁcance diﬀerent
from that of tau hyperphosphorylation. A diﬀerence is notable
in the kinetics of tau hyperphosphorylation and a-synuclein
dephosphorylation after CWS. Tau hyperphosphorylation was
clearly observed immediately after 5 min of CWS, maximal at
20 min, and largely returned to the control level by 60–90 min
(Fig. 3A) [23], whereas a-synuclein phosphoryration level was
no diﬀerent immediately after CWS, lowest at 20 min, and
slowly recovered over several hours. Thus, changes in the
phosphorylation level of a-synuclein are likely to be associated
with certain longer-term neuronal processes.
A knockdown study of a-synuclein in cultured cells [33] and
electrophysiological and ultrastructural studies of a-synuclein
knockout mice [15,16] have shown an impairment in the reg-
ulatory aspect of synaptic transmission, and ultrastructurally,a reduction in the distal pool of synaptic vesicles, implicating
a-synuclein in replenishment of synaptic vesicles at dopamine
synapses after intense activities. Ser129 phosphorylation may
be involved in the regulation of this distal pool. Unregulated
hyperphosphorylation in a pathological context can possibly
interfere with the mechanism sustaining the logistics of syn-
aptic vesicles.
A low percentage (4%) estimated for the phosphorylated
fraction of a-synuclein in the rat brain [17] may invite skepti-
cism as to its signiﬁcance. Our demonstration of stress-re-
sponsive regulation of the phosphorylation level, however,
supports a physiological role. It is tempting to speculate that
this relatively abundant brain protein may occur in multiple
functional compartments, and the phosphorylation is called
for in a particular one.
The observed decrease in a-synuclein phosphorylation after
CWS may reﬂect an aspect of neural responses to stress, as our
preliminary observation indicated that this phenomenon oc-
curs also after ether anesthesia, a classic experimental stress
paradigm.4.3. a-Synuclein phosphorylation and PD
a-Synuclein phosphorylated on Ser129 has been identiﬁed as
the main component of LB characteristic of PD and closely
related diseases [17]. Possible signiﬁcance of a-synuclein
phosphorylation to the etiology of a-synucleinopathy has been
suggested by studies of eﬀect of phosphorylation on the lipid
binding property of a-synuclein [29] and increased tendency to
ﬁbril formation of phosphorylated a-synuclein [17]. A signiﬁ-
cant decrease of dopamine content in the St is the ﬁrst neu-
rochemically observable change in aging mouse brains [26].
Progressive decline of striatal dopamine content with age is
also known in the humans [27]. It is of interest in this context
that the temporary dephosphorylation of a-synuclein induced
by CWS in the aged mouse brain was of lesser magnitude,
particularly in the St compared with the young adults. Further
understanding of the role of a-synuclein phosphorylation in
the St should provide clues to the particular vulnerability of
this brain region to PD.
Acknowledgements: We thank Dr. T. Nonaka for his helpful advice
and discussions and Dr. M. Kobayashi, J. Fujio, and T. Kojima for
valuable comments during this study. We are also grateful to Dr. S.
Kamijo and his team for their expertise. This work was supported in
part by Grants-in-Aid for Scientiﬁc Research-Advanced Brain Science
Project-from Ministry of Education, Science, Sports and Culture,
Japan.References
[1] Spillantini, M.G., Schmidt, M.L., Lee, V.M.-Y., Trojanowski,
J.Q., Jakes, R. and Goedert, M. (1997) Nature 388, 839–840.
[2] Baba, M., Nakajo, S., Tu, P.-H., Tomita, T., Nakaya, K., Lee,
V.M.-Y., Trojanowski, J.Q. and Iwatsubo, T. (1998) Am. J.
Pathol. 152, 879–884.
[3] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E.,
Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer,
R., Srenroos, E.S., Chandrasekharappa, S., Athanassiadou, A.,
Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin,
R.C., Iorio, G.D., Golbe, L.I. and Nussbaum, R.L. (1997) Science
276, 2045–2047.
[4] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M.,
Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O.
(1998) Nat. Genet. 18, 106–108.
232 Y. Hirai et al. / FEBS Letters 572 (2004) 227–232[5] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S.,
Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum,
R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler,
C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D.,
Blancato, J., Hardy, J. and Gwinn-Hardy, K. (2003) Science 302,
841.
[6] Dauer, W. and Przedborski, S. (2003) Neuron 39, 889–909.
[7] Clayton, D.F. and George, J.M. (1998) Trends Neurosci. 21, 249–
254.
[8] Kahle, P.J., Haass, C., Kretzschmar, H.A. and Neumann, M.
(2002) J. Neurochem. 82, 449–457.
[9] Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L.,
Rohan de Silva, H.A., Kittel, A. and Saitoh, T. (1995) Neuron 14,
467–475.
[10] Jakes, R., Spillantini, M.G. and Gordert, M. (1994) FEBS Lett.
345, 27–32.
[11] Irizarry, M.C., Kim, T.W., McNamara, M., Tanzi, R.E., George,
J.M., Clayton, D.F. and Hyman, B.T. (1996) J. Neuropathol. Exp.
Neurol. 55, 889–895.
[12] Davidson, W.S., Jonas, A., Clayton, D.F. and George, J.M.
(1998) J. Biol. Chem. 273, 9443–9449.
[13] Perrin, R.J., Woods, W.S., Clayton, D.F. and George, J.M. (2000)
J. Biol. Chem. 275, 34393–34398.
[14] George, J.M., Jin, H., Woods, W.S. and Clayton, D.F. (1995)
Neuron 15, 361–372.
[15] Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho,
W.-H., Castillo, P.E., Shinsky, N., Verdugo, J.M.G., Armanini,
M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. and Rosenthal,
A. (2000) Neuron 25, 239–252.
[16] Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk,
W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor,
R., Lu, B. and Nussbaum, R.L. (2002) J. Neurosci. 22, 8797–
8807.
[17] Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A.,
Masliah, E., Goldberg, M.S., Shen, J., Takio, K. and Iwatsubo, T.
(2002) Nat. Cell Biol. 4, 160–164.[18] Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K.,
Takahashi, H., Lee, V.M.-Y., Trojanowski, J.Q., Mann, D. and
Iwatsubo, T. (2002) J. Biol. Chem. 277, 49071–49076.
[19] Hasegawa, M., Morishima-Kawashia, M., Takio, K., Suzuki, M.,
Titani, K. and Ihara, Y. (1992) J. Biol. Chem. 267, 17047–17054.
[20] Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki,
M., Titani, K. and Ihara, Y. (1993) Neuron 10, 1151–1160.
[21] Yanagisawa, M., Planel, E., Ishiguro, K. and Fujita, S.C. (1999)
FEBS Lett. 461, 329–333.
[22] Planel, E., Yasutake, K., Fujita, S.C. and Ishiguro, K. (2001)
J. Biol. Chem. 276, 34298–34306.
[23] Okawa, Y., Ishiguro, K. and Fujita, S.C. (2003) FEBS Lett. 535,
183–189.
[24] Saito, Y., Kawashima, A., Ruberu, N.N., Fujiwara, H., Koyama,
S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Haseg-
awa, M., Iwatsubo, T. and Murayama, S. (2003) J. Neuropathol.
Exp. Neurol. 62, 644–654.
[25] Obata, K., Nishiye, H., Fujita, S.C., Shirao, T., Inoue, H. and
Uchizono, K. (1986) Brain Res. 375, 37–48.
[26] Finch, C.E. (1973) Brain Res. 52, 261–276.
[27] Carlsson, A. and Winblad, B. (1976) J. Neural Transm. 38, 271–
276.
[28] Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M.,
Iwatsubo, T., Meijer, L., Kahle, P.J. and Haass, C. (2000) J. Biol.
Chem. 275, 390–397.
[29] Pronin, A.N., Morris, A.J., Surguchov, A. and Benovic, J.L.
(2000) J. Biol. Chem. 275, 26515–26522.
[30] Takahashi, M., Kanuka, H., Fujiwara, H., Koyama, A., Haseg-
awa, M., Miura, M. and Iwatsubo, T. (2003) Neurosci. Lett. 336,
155–158.
[31] Abercrombie, E.D., Keefe, K.A., DiFrischia, S.S. and Zigmond,
M.J. (1989) J. Neurochem. 52, 1655–1658.
[32] Smith, A.D., Castro, S.L. and Zigmond, M.J. (2002) Physiol.
Behav. 77, 527–531.
[33] Murphy, D.D., Rueter, S.M., Trojanowski, J.Q. and Lee, V.M.-Y.
(2000) J. Neurosci. 20, 3214–3220.
